Published by Josh White on 27th March 2017
(ShareCast News) - High-affinity antibody developer and supplier Bioventix announced its unaudited interim financial results for the six months to 31 December on Monday, with turnover rising 32% period-on-period to £3.12m.
URL: http://www.digitallook.com/dl/news/story/25727730/...